AURA

Aura Biosciences, Inc. Common Stock

6.29

USD

AURA Earnings Reports

Positive Surprise Ratio

AURA beat 9 of 16 last estimates.

56%

Next Report

Next Week

Date of Next Report

Mar 31, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.43

Implied change from Q-- -- (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

-17.31%

Aura Biosciences, Inc. Common Stock earnings per share and revenue

On --, AURA reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, -- analysts forecast an EPS of -0.43 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Precigen, Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.01

Surprise

+88.24%

Candel Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.25

Actual

-$0.54

Surprise

-115.31%

Acumen Pharmaceuticals, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.46

Actual

-$0.41

Surprise

+11.29%

Spero Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.20

Actual

$0.53

Surprise

+359.80%

Rani Therapeutics Holdings, Inc. Class A Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.06

Actual

-$0.07

Surprise

-2.94%

Alpha Cognition Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.27

Actual

-$0.30

Surprise

-8.93%

Cognition Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.02

Surprise

+76.47%

Dyadic International, Inc.

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.04

Actual

-$0.06

Surprise

-30.72%

Quantum Biopharma Ltd. Class B Subordinate Voting Shares

Report Date

Mar 26, 2026 For Q4 25

Estimate

Actual

-$0.71

Surprise

CollPlant Biotechnologies Ltd Ordinary Shares

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.19

Actual

-$0.67

Surprise

-245.72%

FAQ

What were Aura Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q-- --?

For Q-- --, Aura Biosciences, Inc. Common Stock reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.

How did the market react to Aura Biosciences, Inc. Common Stock's Q-- -- earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Aura Biosciences, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 31, 2026.

What are the forecasts for Aura Biosciences, Inc. Common Stock's next earnings report?

Based on -- analysts, Aura Biosciences, Inc. Common Stock is expected to report EPS of -$0.43 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.